Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen and Prodesse to Collaborate on Infectious Disease Tests

NEW YORK, Sept. 10 (GenomeWeb News) - Nanogen and Prodesse announced today a collaboration to develop microarray-based tests for infectious disease agents such as influenza, West Nile virus, and SARS.

 

Prodesse, a Milwaukee, Wis.-based firm will provide its multiplex amplification technology for use on San Diego-based Nanogen's NanoChip platform, the companies said in a statement. The two firms will create gene-based testing products for marketing to health care providers and clinical reference labs.

 

Financial details of the deal were not disclosed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.